Skip to contentI
ICU Medical Inc
I
ICUIICU Medical Inc Q1 2024 · 10-Q
Revenue$566.66M$566.66M−0.4% vs Q1 2023 Net Income-$39.47M-$39.47MN/M vs Q1 2023 EPS Diluted-$1.63-$1.63N/M vs Q1 2023 Gross Profit$185,244,000−3.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ICU Medical Inc · CIK 883984 · Engraved from SEC EDGAR
Operating Cash Flow$45,791,000+11.0% Free Cash Flowderived$29,876,000+10.5% Margins · derivedGross margin32.7%−1.1 pt vs Q1 2023
Operating margin-1.9%−3.5 pt vs Q1 2023
Net margin-7.0%−5.2 pt vs Q1 2023
ended Mar 31, 2024 · filed May 7, 2024 · 37 d after period end